Xian-zheng Zhang
Hefei, 230032, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
HIF-1α mediates mitochondrial damage by down-regulating ALKBH7 expression to promote the aberrant activation of FLS in rheumatoid arthritis.
Journal: Acta pharmacologica Sinica
Published: June 22, 2024
The intricate relationship between autoimmunity disease and neutrophils death patterns: a love-hate story.
Journal: Apoptosis : an international journal on programmed cell death
Published: July 11, 2023
The monomer derivative of paeoniflorin inhibits macrophage pyroptosis via regulating TLR4/ NLRP3/ GSDMD signaling pathway in adjuvant arthritis rats.
Journal: International immunopharmacology
Published: June 14, 2021
Paeoniflorin-6'-o-benzene sulfonate (CP-25) improves vasculitis through inhibiting IL-17A/JAK/STAT3 signaling pathway in endothelial cells of HFD CIA rats.
Journal: Phytotherapy research : PTR
Published: April 15, 2020
Etanercept Inhibits B Cell Differentiation by Regulating TNFRII/TRAF2/NF-κB Signaling Pathway in Rheumatoid Arthritis.
Journal: Frontiers in pharmacology
Published: September 19, 2019
IgD-Fc-Ig fusion protein, a new biological agent, inhibits T cell function in CIA rats by inhibiting IgD-IgDR-Lck-NF-κB signaling pathways.
Journal: Acta pharmacologica Sinica
Published: July 10, 2019
Paeoniflorin-6'-O-benzene sulfonate alleviates collagen-induced arthritis in mice by downregulating BAFF-TRAF2-NF-κB signaling: comparison with biological agents.
Journal: Acta pharmacologica Sinica
Published: March 12, 2018
CP-25, a Novel Anti-inflammatory and Immunomodulatory Drug, Inhibits the Functions of Activated Human B Cells through Regulating BAFF and TNF-alpha Signaling and Comparative Efficacy with Biological Agents.
Journal: Frontiers in pharmacology
Published: September 11, 2017
Showing 1-10 of 10
Last Updated: 09/26/2026